Table 1 GEP signatures used in this study.

From: Ratio of the interferon-γ signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma

Signature name

Number of genes

Description

IFN-γ/IMS

28

This work

IFN-γ (44)

6

Averaging the expression levels of the IFN-γ signature genes

Exp. Immu. (44)

18

Averaging the expression levels of the expanded immune genes

Roh Immu. (74)

41

Averaging the expression levels of immune genes

Messina (75)

12

Principal component 1 score from PCA of expression levels of 12 chemokine signature genes

IMPRES (76)

28

Sum of ratios of 15 checkpoint or immune gene pairs

Huang NRS (77)

69

Averaging the expression levels of neoadjuvant response signature (NRS) genes

T eff. (78)

8

Averaging the expression levels of T-effector IFN-γ signature genes

Davoli (79)

7

Averaging the expression levels of cytotoxic immune signature genes

Cytotoxic (80)

2

Averaging the expression levels of granzyme A (GZMA) and perforin (PRF1)